Invivyd, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On June 17, 2022, Anand Shah, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately following adjournment of the Company’s 2022 annual meeting of stockholders, which will be held on June 22, 2022.
Extracted from this filing and checked against the source text.
Anand Shah resigned as director at Invivyd, Inc..
On June 17, 2022, Anand Shah, M.D. notified Adagio Therapeutics, Inc. (the “Company”) of his decision to resign from the board of directors of the Company and all committees thereof, effective immediately following adjournment of the Company’s 2022 annual meeting of stockholders, which will be held on June 22, 2022.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.